Patents by Inventor Nigel Paul Michael

Nigel Paul Michael has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7662973
    Abstract: Disclosed is a method for increasing the fluorescence of a Cyanine dye molecule comprising at least one NO2 group characterized by the reduction of the at least one NO2 group to NHOH or NH2 by the action of a nitroreductase. The cyanine dye molecule comprising at least one NO2 group can be used as a substrate for detecting nitroreductase enzyme activity in a composition and allows for the use of a nitroreductase enzyme in an enzyme-reporter system for the detection of analytes, binding reactions or gene expression.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: February 16, 2010
    Assignee: GE Healthcare UK Limited
    Inventors: Nicholas Thomas, Nigel Paul Michael, Valerie Millar, Beth Davies, Mark Samuel Jonathan Briggs
  • Patent number: 7300762
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein (SEQ ID NO: 2). The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: November 27, 2007
    Assignee: GE Healthcare UK Limited
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Patent number: 7091317
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: January 14, 2004
    Date of Patent: August 15, 2006
    Assignee: GE Healthcare Limited
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Patent number: 6919186
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 19, 2005
    Assignee: Amersham plc
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Publication number: 20040138420
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S 175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 15, 2004
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Publication number: 20030186348
    Abstract: Disclosed is a method for increasing the fluorescence of a Cyanine dye molecule comprising at least one NO2 group characterised by the reduction of the at least one NO2 group to NHOH or NH2 by the action of a nitroreductase. The cyanine dye molecule comprising at least one NO2 group can be used as a substrate for detecting nitroreductase enzyme activity in a composition and allows for the use of a nitroreductase enzyme in an enzyme-reporter system for the detection of analytes, binding reaction or gene expression.
    Type: Application
    Filed: October 16, 2002
    Publication date: October 2, 2003
    Inventors: Nicholas Thomas, Nigel Paul Michael, Valerie Millar, Beth Davies, Mark Samuel Jonathan Briggs
  • Publication number: 20030175859
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Application
    Filed: September 28, 2001
    Publication date: September 18, 2003
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas